Prolonged treatment with the proteasome inhibitor MG-132 induces apoptosis in PC12 rat pheochromocytoma cells

Sci Rep. 2022 Apr 6;12(1):5808. doi: 10.1038/s41598-022-09763-z.

Abstract

Rat pheochromocytoma (PC12) cells were treated with the proteasome inhibitor MG-132 and morphological changes were recorded. Initially, neuronal differentiation was induced but after 24 h signs of morphological deterioration became apparent. We performed nuclear staining, flow cytometry and WST-1 assay then analyzed signal transduction pathways involving Akt, p38 MAPK (Mitogen-Activated Protein Kinase), JNK (c-Jun N-terminal Kinase), c-Jun and caspase-3. Stress signaling via p38, JNK and c-Jun was active even after 24 h of MG-132 treatment, while the survival-mediating Akt phosphorylation declined and the executor of apoptosis (caspase-3) was activated by that time and apoptosis was also observable. We examined subcellular localization of stress signaling components, applied kinase inhibitors and dominant negative H-Ras mutant-expressing PC12 cells in order to decipher connections of stress-mediating pathways. Our results are suggestive of that treatment with the proteasome inhibitor MG-132 has a biphasic nature in PC12 cells. Initially, it induces neuronal differentiation but prolonged treatments lead to apoptosis.

MeSH terms

  • Adrenal Gland Neoplasms
  • Animals
  • Apoptosis / physiology
  • Caspase 3
  • Enzyme Activation
  • JNK Mitogen-Activated Protein Kinases
  • Leupeptins*
  • PC12 Cells
  • Pheochromocytoma
  • Proteasome Inhibitors* / pharmacology
  • Proto-Oncogene Proteins c-akt
  • Rats
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Leupeptins
  • Proteasome Inhibitors
  • Proto-Oncogene Proteins c-akt
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Caspase 3
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde